Clinical value of molecular MRD monitoring by next-generation sequencing in patients with

MLA

Evgenii, Shumilov, et al. “Clinical Value of Molecular MRD Monitoring by Next-Generation Sequencing in Patients With.” Leukemialymphoma, vol. 60, no. 10, Apr. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........46fc7be1619fcf67cc30c69d46d661af&authtype=sso&custid=ns315887.

APA

Evgenii, S., Johanna, F., Raphael, J., Naomi, P., Gertrud, W., Urban, N., Eva, G., Barbara, J., Ursula, A., Thomas, P., & Ulrike, B. (2019). Clinical value of molecular MRD monitoring by next-generation sequencing in patients with. Leukemialymphoma, 60(10).

Chicago

Evgenii, Shumilov, Flach Johanna, Joncourt Raphael, Porret Naomi, Wiedemann Gertrud, Novak Urban, Gfeller Eva, et al. 2019. “Clinical Value of Molecular MRD Monitoring by Next-Generation Sequencing in Patients With.” Leukemialymphoma 60 (10). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........46fc7be1619fcf67cc30c69d46d661af&authtype=sso&custid=ns315887.